醫藥瓶市場－全球產業規模、佔有率、趨勢、機會與預測：按瓶型、應用、最終用戶、地區和競爭格局分類，2021-2031年

全球藥品瓶市場預計將從 2025 年的 74.9 億美元成長到 2031 年的 94.7 億美元，複合年成長率為 3.99%。

這些由玻璃或塑膠製成的瓶子是必不可少的硬質初級包裝，旨在保護液體和固體藥品的穩定性和完整性。這一成長主要得益於學名藥行業的快速擴張，這顯著提升了對堅固耐用且經濟高效的包裝解決方案的需求；此外，全球範圍內需要長期治療的慢性病患病率不斷上升也是推動這一成長的重要因素。

儘管市場呈現強勁成長趨勢，但由於原料和能源價格的不可預測波動，市場面臨嚴峻挑戰，這阻礙了生產計畫，並降低了利潤率。歐洲製藥廠商協會聯合會（EFPIA）的報告預測，到2024年，光是北美地區就將佔全球藥品銷售額的54.8%。這種對成熟市場需求的集中，給製造商帶來了越來越大的壓力，迫使他們在經濟不確定性中維持供應鏈的可靠性。

市場促進因素

推動藥品包裝瓶產量成長的主要因素是慢性病發生率的上升和全球老化社會的加劇。隨著糖尿病和心血管疾病等非傳染性疾病發病率的增加，對用於安全輸送液體糖漿和固態口服藥物的硬質包裝解決方案的需求也日益成長。這一趨勢迫使製造商大幅擴大生產規模，以滿足長期治療所需的包裝容器需求，並確保藥品的充足供應。例如，肖特製藥公司（Schott Pharma）2023年度報告（2024年1月發布）顯示，該公司已交付約130億個藥品包裝容器解決方案，凸顯了當前患者照護所需的巨大產能的重要性。

此外，隨著製藥業加大對永續和可回收解決方案的投入，藥品包裝市場正在經歷重組，這影響著原料採購和生產流程。製藥公司正逐步從使用原生聚合物轉向使用再生樹脂和輕質玻璃，以達到環保目標並減少碳足跡。主要包裝供應商正在將循環經濟原則融入其生產流程。例如，Bormioli Pharma 發布的 2023 年 ESG 報告（2024 年 7 月發布）顯示，其玻璃熔融製程中再生材料的使用量增加了 45%。鑑於出口市場的擴張，這種轉變至關重要。例如，預計到 2024 年，印度的藥品出口額將達到 278.5 億美元（印度品牌股權基金會），這就需要符合國際環境標準的包裝。

市場挑戰

全球醫藥包裝瓶市場穩定成長面臨的主要障礙是原物料價格和能源成本的不可預測波動。玻璃和塑膠容器的生產都涉及高能耗工藝，例如玻璃熔爐的運作和塑膠的聚合。能源成本的波動使得包裝供應商難以準確預測生產成本，也難以為製藥公司設定穩定的價格。這種波動直接降低了利潤率，迫使製造商在自行承擔增加的成本並限制業務擴張投資，或將這些成本轉嫁給製藥公司之間做出選擇。後者可能導致需求下降，尤其是在對成本敏感的學名藥領域。

此外，能源成本的區域差異會造成競爭格局失衡，擾亂全球供應鏈，並使長期製造策略複雜化。主要生產地區能源價格飆升可能導致產量下降和供不應求，阻礙整體市場成長。根據歐洲化學工業理事會 (Cefic) 2024 年的報告顯示，歐盟天然氣價格比 2014-2019 年期間上漲了 76%。持續高企業的能源成本給原料供應商帶來了巨大的財務壓力，使得以具有競爭力的價格生產藥用級瓶子變得越來越困難，並對全球供應鏈的可靠性產生了負面影響。

市場趨勢

透過數位化連接，智慧藥物管理技術的融合正在改變藥品瓶市場，解決用藥依從性難題。製造商正擴大近距離場通訊 (NFC) 標籤和藍牙感測器直接整合到瓶蓋中。這些創新技術能夠即時監測用藥依從性，並將數據傳輸到連接的行動應用程式，使醫療專業人員能夠遠端追蹤治療進展，並將處方治療方案與患者的實際用藥情況進行核對。 Aptar 的 2024 年年度報告（2025 年 3 月發布）重點強調了這一趨勢，報告顯示，其數位健康生態系統中互聯管理應用程式的用戶數量已超過 300 萬。這反映出消費者對科技驅動的用藥依從性解決方案的快速接受。

同時，防偽序列化功能的廣泛應用正成為防止假藥在全球供應鏈中擴散的重要標準。監管要求包裝供應商必須實施先進的追蹤溯源系統，例如2D資料矩陣碼和防篡改封條。這些功能檢驗從生產到分發的整個過程中藥瓶的真偽，其根本目的是為了保護分銷網路免受透過不受監管的線上管道銷售的非法產品的侵害。國際刑警組織在2025年6月發布的「盤古行動XVII」新聞稿中指出，該行動在全球範圍內查獲了5040萬劑非法藥品，凸顯了應對這一嚴峻安全挑戰的必要性，也因此需要此類強大且檢驗的包裝技術。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫藥瓶市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 瓶子類型（滴管瓶、液體瓶、包裝瓶）
  • 透過應用（滴管、電子菸液、液體、口腔護理）
  • 依最終用戶分類（化學工業、配藥藥房、醫療機構、製藥公司、藥品包裝）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美藥品瓶市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲藥品包裝瓶市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區藥品瓶市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲藥品瓶市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲藥品包裝瓶市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球醫藥瓶市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Berry Plastics Group Inc.
• Amcor Limited
• Gerresheimer AG
• Aptar Pharma
• Westrock Company
• Beckton and Dickinson Co.
• West Pharmaceuticals Services Inc.
• Schott AG
• Nipro Corporation
• O.Berk Company LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The global market for pharmaceutical bottles is projected to expand from USD 7.49 billion in 2025 to USD 9.47 billion by 2031, demonstrating a compound annual growth rate of 3.99%. These bottles, crafted from glass or plastic, serve as essential rigid primary packaging, designed to safeguard the stability and integrity of both liquid and solid medications. This growth is largely fueled by the rising global prevalence of chronic diseases, necessitating extensive and long-term treatment, coupled with the burgeoning generic medicine sector, which significantly boosts demand for robust and cost-effective packaging solutions.

Despite this positive growth trajectory, the market faces a substantial challenge from the unpredictable fluctuations in raw material and energy prices, which hinder production planning and diminish profit margins. In 2024, North America alone represented 54.8% of the world's estimated pharmaceutical sales, as reported by the European Federation of Pharmaceutical Industries and Associations. This concentration of demand in well-established markets intensifies pressure on manufacturers to ensure consistent supply chain reliability amidst economic uncertainties.

Market Driver

A primary driver for the increased production of pharmaceutical bottles is the global rise in chronic diseases and the expanding elderly population. The escalating incidence of non-communicable conditions like diabetes and cardiovascular diseases necessitates a greater demand for rigid packaging solutions to safely distribute both liquid syrups and solid oral medications. This trend compels manufacturers to expand their operations significantly to meet the containment requirements of long-term treatments and guarantee widespread medication availability. For instance, Schott Pharma's 2023 Annual Report (January 2024) indicated the delivery of drug containment solutions for approximately 13 billion doses, underscoring the immense operational capacity needed for current patient care.

Furthermore, the pharmaceutical packaging market is being reshaped by the industry's increasing embrace of sustainable and recyclable solutions, influencing material procurement and manufacturing processes. Pharmaceutical firms are progressively moving from virgin polymers to recycled resins and lightweight glass to meet environmental objectives and reduce their carbon footprint. Major packaging suppliers are incorporating circular economy principles into their production, as demonstrated by Bormioli Pharma's 2023 ESG Report (July 2024), which reported a 45% increase in recycled raw materials in its glass melting process. This shift is vital given the expansion of export markets, such as India's drug and pharmaceutical exports reaching US$ 27.85 billion in 2024 (India Brand Equity Foundation), which demands packaging that adheres to international environmental standards.

Market Challenge

A significant obstacle to the Global Pharmaceutical Bottles Market's stability and growth is the unpredictable fluctuation in raw material prices and energy costs. Producing both glass and plastic containers involves energy-intensive methods, such as operating melting furnaces for glass and polymerization for plastics. Unstable energy costs make it challenging for packaging suppliers to accurately predict production expenses and offer consistent pricing to pharmaceutical clients. This instability directly reduces profit margins, compelling manufacturers to either absorb higher costs, thereby limiting investment in expansion, or pass these costs to pharmaceutical companies, which can diminish demand, especially within cost-sensitive generic medicine segments.

Moreover, varying energy costs across different regions create an uneven competitive landscape, disrupting global supply chains and complicating long-term manufacturing strategies. Elevated energy prices in crucial production areas can lead to reduced output and supply shortages, impeding the market's overall growth. As reported by the European Chemical Industry Council (Cefic) in 2024, gas prices in the EU were 76% higher than their pre-2014-2019 levels. Such persistent high energy expenses impose substantial financial pressure on material suppliers, making the competitive production of pharmaceutical-grade bottles increasingly difficult and negatively impacting the reliability of the worldwide supply chain.

Market Trends

The pharmaceutical bottles market is being transformed by the integration of smart adherence technologies, which tackle medication non-compliance through digital connectivity. Manufacturers are increasingly incorporating Near Field Communication (NFC) tags and Bluetooth-enabled sensors directly into bottle closures. These innovations enable real-time monitoring of dosage events and data transmission to linked mobile applications, allowing healthcare providers to remotely track therapeutic progress and reconcile prescribed regimens with actual patient adherence. Aptar's 2024 Annual Report (March 2025) highlighted this trend, showing its digital health ecosystem's connected management application exceeding 3 million users, reflecting swift consumer uptake of technology-enhanced adherence solutions.

Concurrently, the extensive adoption of anti-counterfeiting serialization features is becoming an essential standard to combat the spread of counterfeit medicines within global supply chains. Regulatory requirements are mandating that packaging suppliers implement sophisticated track-and-trace systems, including 2D data matrix codes and tamper-evident seals. These features verify bottle authenticity from production to dispensing, driven by the critical need to safeguard distribution networks against illicit products, particularly those sold through unregulated online channels. Interpol's 'Operation Pangea XVII' press release (June 2025) reported the seizure of 50.4 million doses of illicit pharmaceuticals globally, underscoring the significant security challenge that necessitates these robust, verifiable packaging technologies.

Key Market Players

• Berry Plastics Group Inc.
• Amcor Limited
• Gerresheimer AG
• Aptar Pharma
• Westrock Company
• Beckton and Dickinson Co.
• West Pharmaceuticals Services Inc.
• Schott AG
• Nipro Corporation
• O.Berk Company LLC

Report Scope

In this report, the Global Pharmaceutical Bottles Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Bottles Market, By Bottle

• Dropper Bottles
• Liquid Bottles
• Packer Bottles

Pharmaceutical Bottles Market, By Application

• Droppers
• E-Liquid
• Liquid
• Oral Care

Pharmaceutical Bottles Market, By End-User

• Chemical
• Compounding Pharmacies
• Healthcare Centers
• Pharmaceutical
• Pharmaceutical Packaging

Pharmaceutical Bottles Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Bottles Market.

Available Customizations:

Global Pharmaceutical Bottles Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Bottles Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bottle (Dropper Bottles, Liquid Bottles, Packer Bottles)
  • 5.2.2. By Application (Droppers, E-Liquid, Liquid, Oral Care)
  • 5.2.3. By End-User (Chemical, Compounding Pharmacies, Healthcare Centers, Pharmaceutical, Pharmaceutical Packaging)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Pharmaceutical Bottles Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bottle
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Bottles Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bottle
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Pharmaceutical Bottles Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bottle
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Pharmaceutical Bottles Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bottle
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Pharmaceutical Bottles Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bottle
  • 7.2.2. By Application
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Bottles Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bottle
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Pharmaceutical Bottles Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bottle
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Pharmaceutical Bottles Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bottle
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Pharmaceutical Bottles Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bottle
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Pharmaceutical Bottles Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bottle
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia Pacific Pharmaceutical Bottles Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bottle
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Bottles Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bottle
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Pharmaceutical Bottles Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bottle
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Pharmaceutical Bottles Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bottle
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Pharmaceutical Bottles Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Bottle
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Pharmaceutical Bottles Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Bottle
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Pharmaceutical Bottles Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bottle
  • 9.2.2. By Application
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmaceutical Bottles Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bottle
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Pharmaceutical Bottles Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bottle
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Pharmaceutical Bottles Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bottle
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. South America Pharmaceutical Bottles Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bottle
  • 10.2.2. By Application
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmaceutical Bottles Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bottle
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Pharmaceutical Bottles Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bottle
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Pharmaceutical Bottles Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bottle
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmaceutical Bottles Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Berry Plastics Group Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Amcor Limited
• 15.3. Gerresheimer AG
• 15.4. Aptar Pharma
• 15.5. Westrock Company
• 15.6. Beckton and Dickinson Co.
• 15.7. West Pharmaceuticals Services Inc.
• 15.8. Schott AG
• 15.9. Nipro Corporation
• 15.10. O.Berk Company LLC

16. Strategic Recommendations

17. About Us & Disclaimer